Your institution may have access to this item. Find your institution then sign in to continue.
Title
From the FDA.
Abstract
The article reports on the new drugs that receive approval from the U.S. Food and Drug Administration (FDA). Buproion hydrobromide (Aplenzin) from Biovail Corp. has been approved for the treatment of major depressive disorder in adults. The FDA also approved the first generic divalproex sodium for the treatment of seizures, bipolar disorder and migraine headaches.